Lysogene's Series A Round

Lysogene raised a round of funding on May 22, 2014.

Lysogene is a clinical stage biotechnology company committed to the development of innovative therapies for patients affected with rare disorders and high unmet medical needs. Lysogene's team translat…

Articles about Lysogene's Series A Round: